IL61930A - 25-hydroxy-26,26,26,27,27,27-hexafluorocholecalciferol and pharmaceutical compositions containing it - Google Patents

25-hydroxy-26,26,26,27,27,27-hexafluorocholecalciferol and pharmaceutical compositions containing it

Info

Publication number
IL61930A
IL61930A IL61930A IL6193081A IL61930A IL 61930 A IL61930 A IL 61930A IL 61930 A IL61930 A IL 61930A IL 6193081 A IL6193081 A IL 6193081A IL 61930 A IL61930 A IL 61930A
Authority
IL
Israel
Prior art keywords
hexafluorocholecalciferol
hydroxy
pharmaceutical compositions
compositions containing
pharmaceutical
Prior art date
Application number
IL61930A
Other languages
English (en)
Other versions
IL61930A0 (en
Original Assignee
Wisconsin Alumni Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wisconsin Alumni Res Found filed Critical Wisconsin Alumni Res Found
Priority to IL7050581A priority Critical patent/IL70505A/xx
Publication of IL61930A0 publication Critical patent/IL61930A0/xx
Priority to IL70505A priority patent/IL70505A0/xx
Publication of IL61930A publication Critical patent/IL61930A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J17/00Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
IL61930A 1980-02-04 1981-01-19 25-hydroxy-26,26,26,27,27,27-hexafluorocholecalciferol and pharmaceutical compositions containing it IL61930A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IL7050581A IL70505A (en) 1980-02-04 1981-01-19 3beta,25-dihydroxy-26,26,26,27,27,27-hexafluoro-cholest-5-ene and-cholesta-5,7-diene and 3beta-ester and ether derivatives thereof
IL70505A IL70505A0 (en) 1980-02-04 1983-12-21 3beta,25-dihydroxy-26,26,26,27,27,27-hexafluoro-cholest-5-ene and cholesta-5,7-diene and 3beta-ester and ether derivatives thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/118,149 US4248791A (en) 1980-02-04 1980-02-04 25-Hydroxy-26,26,26,27,27,27-hexafluorocholecalciferol

Publications (2)

Publication Number Publication Date
IL61930A0 IL61930A0 (en) 1981-02-27
IL61930A true IL61930A (en) 1984-11-30

Family

ID=22376765

Family Applications (1)

Application Number Title Priority Date Filing Date
IL61930A IL61930A (en) 1980-02-04 1981-01-19 25-hydroxy-26,26,26,27,27,27-hexafluorocholecalciferol and pharmaceutical compositions containing it

Country Status (12)

Country Link
US (1) US4248791A (fr)
AU (1) AU544294B2 (fr)
BE (1) BE887344A (fr)
CH (2) CH651295A5 (fr)
DK (1) DK436981A (fr)
FR (1) FR2477145B1 (fr)
GB (2) GB2082586B (fr)
IE (1) IE50815B1 (fr)
IL (1) IL61930A (fr)
IT (1) IT1194789B (fr)
NZ (1) NZ196039A (fr)
WO (1) WO1981002298A1 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4248791A (en) * 1980-02-04 1981-02-03 Wisconsin Alumni Research Foundation 25-Hydroxy-26,26,26,27,27,27-hexafluorocholecalciferol
US4358406A (en) * 1981-07-27 1982-11-09 Wisconsin Alumni Research Foundation 26,26,26,27,27,27-Hexafluoro-1α,25-dihydroxycholecalciferol and process for preparing same
US4411833A (en) * 1982-05-26 1983-10-25 Wisconsin Alumni Research Foundation Method for preparing 26,26,26,27,27,27-hexafluoro-1α,25-dihydroxycholesterol
JPS59500864A (ja) * 1982-05-26 1984-05-17 ウイスコンシン アラムナイ リサ−チ フオンデ−シヨン 26,26.26,27.27,27―ヘキサフルオロ―1α,25―ジヒドロキシコレステロール化合物及びその製造方法
US4613594A (en) * 1984-11-16 1986-09-23 Hoffmann-La Roche Inc. Fluorinated vitamin D3 compounds
ZA859138B (en) * 1984-12-19 1986-08-27 Hoffmann La Roche Cholecalciferol derivatives
EP0205025A1 (fr) * 1985-05-27 1986-12-17 Sumitomo Pharmaceuticals Company, Limited Dérivés fluorés de vitamine D3 et agents inducteurs de différentiation cellulaire les contenant comme composé actif
JPH0764804B2 (ja) * 1986-04-25 1995-07-12 住友製薬株式会社 活性型ビタミンd3のフッ素誘導体
CA1314872C (fr) 1986-04-25 1993-03-23 Toshio Nishizawa Derives fluores de la vitamine d _et procede pour leur production
US4853378A (en) * 1986-10-20 1989-08-01 Sumitomo Chemical Company, Limited Fluorine derivatives of vitamin D3 and process for producing the same
JPS63196556A (ja) * 1987-02-10 1988-08-15 Taisho Pharmaceut Co Ltd 含フツ素ビタミンd誘導体
JPH0737476B2 (ja) * 1991-01-17 1995-04-26 ウイスコンシン アラムナイ リサーチ フオンデーシヨン 26,26,26,27,27,27−ヘキサフルオロ−1α,25−ジヒドロキシコレステロール
US5571802A (en) * 1993-02-19 1996-11-05 Wisconsin Alumni Research Foundation Method of treating post menopausal osteoporosis with hexafluro-vitamin D
US5428029A (en) * 1993-11-24 1995-06-27 Hoffmann-La Roche Inc. Vitamin D3 fluorinated analogs
JP5932339B2 (ja) * 2009-01-27 2016-06-08 バーグ エルエルシー 化学療法に付随する副作用を軽減するためのビタミンd3およびその類似体
IN2012DN02137A (fr) 2009-08-14 2015-08-07 Berg Biosystems Llc
NZ599216A (en) * 2009-10-02 2014-01-31 Wisconsin Alumni Res Found 1-desoxy-2-methylene-19-nor-vitamin d analogs and their uses
SG10201709894RA (en) 2013-05-29 2018-01-30 Berg Llc Preventing or mitigating chemotherapy induced alopecia using vitamin d
GB2581656A (en) * 2017-11-17 2020-08-26 Piraee Mahmood Combinations of lanosterol or 25-hydroxycholesterol including derivatives thereof useful in the treatment of lens disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4069321A (en) * 1975-10-14 1978-01-17 Merck & Co., Inc. Blocked cholecalciferol and dihydrotachysterol 3 derivatives
US4196133A (en) * 1979-03-05 1980-04-01 Wisconsin Alumni Research Foundation 24,24-Difluoro-25-hydroxycholecalciferol
US4248791A (en) * 1980-02-04 1981-02-03 Wisconsin Alumni Research Foundation 25-Hydroxy-26,26,26,27,27,27-hexafluorocholecalciferol

Also Published As

Publication number Publication date
FR2477145A1 (fr) 1981-09-04
DK436981A (da) 1981-10-02
BE887344A (fr) 1981-06-01
CH651295A5 (de) 1985-09-13
GB2082586A (en) 1982-03-10
IT1194789B (it) 1988-09-28
GB2068382A (en) 1981-08-12
FR2477145B1 (fr) 1985-09-20
IT8119459A0 (it) 1981-02-02
IE810196L (en) 1981-08-04
WO1981002298A1 (fr) 1981-08-20
CH652725A5 (de) 1985-11-29
IL61930A0 (en) 1981-02-27
AU6684681A (en) 1981-08-13
GB2082586B (en) 1983-10-05
AU544294B2 (en) 1985-05-23
IE50815B1 (en) 1986-07-23
GB2068382B (en) 1984-02-29
NZ196039A (en) 1983-07-15
US4248791A (en) 1981-02-03

Similar Documents

Publication Publication Date Title
IL63968A0 (en) Aminoalkylfuran derivative,its preparation and pharmaceutical compositions containing it
IL65056A0 (en) Imidazodiazepines,their manufacture and pharmaceutical compositions containing them
IL61930A (en) 25-hydroxy-26,26,26,27,27,27-hexafluorocholecalciferol and pharmaceutical compositions containing it
ZA818371B (en) Nortropanols,their preparation and pharmaceutical compositions containing these
IL63801A0 (en) 2-amino-3-carbethoxyamino-6-(p-fluorobenzylamino)-pyridine-maleate,its production and pharmaceutical compositions containing it
DE3168067D1 (en) 2-guanidino-4-heteroarylthiazoles and pharmaceutical compositions containing them
IL63368A0 (en) 4,5-diaryl-alpha-polyfluoroalkyl-1h-imidazole-2-methanamines,their preparation and pharmaceutical compositions containing them
DE3167679D1 (en) Pharmaceutical forms, their preparation and compositions containing the same
DE3069074D1 (en) 6-alpha-9-alpha-difluoro-16-beta-methyl-prednisolone-17,21 diesters and pharmaceutical compositions containing them
IL58526A (en) 24,24-difluoro-1alpha,25-dihydroxycholecalciferol and pharmaceutical compositions containing it
IL64054A (en) Imidazolylpyridines and pharmaceutical compositions containing them
IL63773A0 (en) Penicillanoyloxymethyl penicillanate 1,1,1',1'-tetraoxide,its preparation and pharmaceutical compositions containing it
IL67284A (en) N-substituted-2-pyridylindoles,their manufacture and pharmaceutical compositions containing them
GB2072504B (en) Pharmaceutical compositions
IL62660A0 (en) 4,5-diaryl-alpha-(polyfluoroalkyl)-1h-pyrrole-2-methanamines,their preparation and pharmaceutical compositions containing them
IL64563A0 (en) 3,4-bis-substituted 1,2,5-oxidiazole 2-oxides,their preparation and pharmaceutical compositions containing them
IL64252A (en) 3,3-dimethyl-indolin-2-ones,their preparation and pharmaceutical compositions containing them
IL62495A0 (en) Pyrimidyl-quinazolines,their preparation and pharmaceutical compositions containing them
IL62592A0 (en) Phenyl-quinolizidines,their manufacture and pharmaceutical compositions containing them
DE3176849D1 (en) Pharmaceutical composition comprising 4-carbamoyl-imidazolium-5-olate
IL61862A0 (en) 4,5-diaryl- -(polyhaloalkyl)-1h-imidazole-2-methanols,their preparation and pharmaceutical compositions containing them
IL63917A0 (en) 2-aminoimidazoles,their manufacture and pharmaceutical compositions containing them
IL62606A0 (en) Pyrrolylpiperidines,their preparation and pharmaceutical compositions containing them
IL62146A0 (en) Guanylamidines and pharmaceutical compositions containing them
ZA814056B (en) Pharmaceutical bicyclo-octatriene compounds and compositions